AF
BBNX icon

Allworth Financial’s Beta Bionics BBNX Stock Holding History

Allworth Financial’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1K Buy
709
+471
+198% +$5.6K ﹤0.01% 3643
2026
Q1 		$2.38K Buy
238
+219
+1,153% +$3.24K ﹤0.01% 4293
2025
Q4 		$579 Buy
19
+17
+850% +$454 ﹤0.01% 4496
2025
Q3 		$40 Buy
+2
New +$35 ﹤0.01% 4771

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Allworth Financial's BBNX Position: Q2 2026 in Review

Allworth Financial increased its Beta Bionics (BBNX) stake by 198% in Q2 2026, buying an estimated $5.6K and bringing the position to 709 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3643.

Allworth Financial first reported a position in BBNX in Q3 2025 and has held it in 4 quarters since. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • Allworth Financial held 709 shares of Beta Bionics worth $11.1K as of Q2 2026.
  • Allworth Financial bought 471 Beta Bionics shares in Q2 2026, an estimated $5.6K.
  • Beta Bionics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3643 holding.
  • Allworth Financial first reported a position in Beta Bionics in Q3 2025 and has held it in 4 quarters since.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.